Skip to main content

Table 1 Patient characteristics

From: A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda

Patient characteristics

Numbers (n)

Percentages (%)

Age (years)

 < 15

56

6.0

 ≥ 15

954

94.0

 Total

1010

100

Gender

 Female

621

61.4

 Male

389

38.5

 Total

1010

100

INH dose (mg/day)

 150

56

6.0

 300

954

94.0

 Total

1010

100

HIV status

 Positive

1010

100

 Negative

0

0

 Total

1010

100

ART status

 Already on ART

1010

0

 Not on ART

0

0

 Total

1010

100